ANTIVIRAL THERAPY IN VIRAL HEPATITIS “C” DISEASE EFFICIENCY (A CASE FROM PRACTICE)

ORZIKULOV Azam Orzikulovich, HAYDAROV Akbar Haydarovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2025-yil

Annotatsiya

ViralhepatitisCis a diseasethatcausesserioushealthproblemsallover the world. The lack of specificprevention of chronicviralhepatitisCis an importantmedicalandsocialprobleminconnection with the development of cirrhosis of the liver,basedonthefactthatat the initialstage the clinicalsigns are nonspecific. The guidelinesandstandardsrecommendedforuseinthetreatment of chronicviralhepatitisCindicatethat the maingoal of therapyis the long-termsuppression of viralreplication.Thearticlementionsthatinclinicalpractice, in the case of "ChronicviralhepatitisC", the administration of the antiviraldrugLedvir(sofosbuvir400mg+ledispavir90mg)for a shortperiodduringclinical and laboratorymonitoringleadsto a positivechange in clinical and laboratorysigns,in the longterm–toprolongedsuppression of virusreplication.

Maqola ma’lumotlari
MualliflarORZIKULOV Azam Orzikulovich, HAYDAROV Akbar Haydarovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2025-03-18
Jild10
Son1
TilO‘zbek

Kalit so‘zlar

вирус гепатита С, вирусная репликация, генотип HCV, генотип 1B, hepatitis C virus, viral replication, HCV genotype, genotype 1B, gepatit S virusi, virus replikatsiyasi, HCV genotipi, 1b genotip

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar